Major regulatory milestone paves the way for commercialization and marks first step toward broader CxM biomarker sensing strategy
BASEL, Switzerland, June 17, 2026 /PRNewswire/ -- FiberSense AG ("FiberSense") today announced that the FiberSense Continuous Glucose Monitoring (CGM) System has obtained CE marking under Regulation (EU) 2017/745 as a Class IIb medical device.
The system is intended for the continuous monitoring of blood sugar levels and glucose trends in adults with diabetes. Based on advanced optical sensing technology, it measures glucose concentrations in the tissue fluid beneath the skin.
To support longer wear and reduce routine replacements, the system's optical sensor and overtape can be worn for up to 28 days before replacement, while the detector and charger have been designed for repeat use.
"This certification is a defining milestone for FiberSense," said Michael Tillmann, Chairman & CEO of FiberSense AG. "After years of dedicated development, our focus now turns to manufacturing scale-up and commercialization."
With CE marking achieved, FiberSense is now advancing the transition from regulatory certification to commercial readiness. The company is preparing manufacturing ramp-up, logistics, customer support and market access activities for selected launch markets, with initial orders already confirmed and first deliveries expected in late 2026.
Continuous glucose monitoring is the first regulated application of FiberSense's planned continuous multi-analyte ("CxM") platform. While the current approved intended use is continuous glucose monitoring in adults with diabetes, FiberSense continues to advance its CxM pipeline, with ketones, lactate and cortisol among the next sensor targets under evaluation.
"The FiberSense CGM System represents the first regulated application of our long-term strategy," Tillmann commented. "The goal is to explore additional opportunities in continuous biomarker sensing beyond glucose and develop a platform solution that may one day support additional analytes and applications, provided it is supported by the necessary scientific, clinical and regulatory evidence."
Contact FiberSense
+49 (0)6026 942 121
media@fibersense-cxm.com
www.fibersense-cxm.com
About FiberSense
FiberSense AG, headquartered in Basel, Switzerland, is an optical biomarker sensing company focused on health and medical technology. Building on the experience of EyeSense, a spin-off from CIBA Vision, formerly part of Novartis, FiberSense combines optical sensing expertise with the ambition to develop innovative, long-wear monitoring solutions for everyday use.
Regulatory and forward-looking note
The FiberSense CGM System is a CE-marked Class IIb medical device under Regulation (EU) 2017/745 and is intended for continuous glucose monitoring in adults with diabetes in accordance with the Instructions for Use. Product availability, first deliveries and future applications beyond glucose remain subject to applicable regulatory, quality, manufacturing, commercial and market-specific requirements.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
FiberSense Continuous Glucose Monitoring (CGM) System obtains CE mark as commercial launch preparations begin
PROVIDENCIALES, Turks and Caicos Islands, June 17, 2026 /PRNewswire/ -- KuCoin, a leading global crypto platform built on trust, today announced the launch of the KuCoin Wealth Quant Fund, introducing its first product, the Neutral Enhanced Fund. Designed for high-net-worth users, the fund brings professionally managed, market-neutral digital asset strategies into the KuCoin Wealth experience, offering a more structured approach to long-term capital allocation, risk management and portfolio diversification.
As the digital asset market matures, investor needs are moving beyond simple market access, spot trading and basic yield products. High-net-worth users and professional investors are increasingly focused on how to manage digital assets more effectively across market cycles, activate existing holdings, reduce reliance on one-sided market exposure and gain greater clarity around strategy, fees, liquidity and risk.
This shift is revealing a layer of demand between conventional crypto yield products and institutional-style private fund solutions. While basic Earn products are accessible, they may not fully meet the needs of users seeking more advanced allocation strategies. Private funds and institutional solutions, meanwhile, can involve higher thresholds, longer processes and less standardized access. In response to this market demand, KuCoin Wealth Quant Fund was designed to provide access to a professional market-neutral strategy through an exchange-native product experience with clear subscription, redemption, NAV and fee mechanisms.
The Neutral Enhanced Fund employs quantitative market-neutral strategies, including arbitrage and long-short trading, with the goal of minimizing dependence on overall market movements. Designed to offer both accessibility and flexibility, the fund is denominated in USDT, has a relatively low minimum subscription requirement of 50,000 USDT, and features a 30-day lock-up period, providing investors with greater liquidity than many longer-term alternatives. Transparency is also a key feature of the fund. There are no subscription or management fees, and performance fees are charged only when an investor's NAV surpasses their individual high-water mark and generates new gains. No performance fee is incurred during drawdown periods or when the NAV remains below the high-water mark, ensuring that fees are closely aligned with actual investment results.
Supported by an independent custody framework, sub-account management, real-time monitoring and comprehensive risk controls, KuCoin Wealth Quant Fund reflects KuCoin's broader commitment to building trusted, transparent and responsible digital asset wealth management solutions for users moving from trading toward long-term allocation.
About KuCoin
Founded in 2017, KuCoin is a leading global crypto platform trusted by over 40 million users across 200+ countries and regions. Known for its user-first approach, the platform combines advanced technology, deep liquidity, and strong security safeguards to deliver a seamless trading experience. KuCoin provides access to 1,500+ digital assets through a broad product suite and remains committed to building transparent, compliant, and user-centric digital asset infrastructure for the future of finance, backed by SOC 2 Type II, ISO/IEC 27001:2022, and ISO/IEC 27701:2019 Certifications. In recent years, we have built a strong global compliance foundation, marked by key milestones including AUSTRAC registration in Australia, a MiCA license in Europe, and regulatory progress in other markets.
Learn more at www.kucoin.com.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
KuCoin Wealth Introduces Its First Quant Fund as Demand Grows for Professional Digital Asset Allocation
